🎈 Up Big Today: Find today's biggest gainers with our free screenerTry Stock Screener

TriSalus Life Sciences Inc (TLSI)

NASDAQ
Currency in USD
3.920
+0.070(+1.82%)
Real-time Data
TLSI Scorecard
Full Analysis
Impressive gross profit margins
Fair Value
Day's Range
3.7703.990
52 wk Range
3.50010.420
Key Statistics
Edit
Prev. Close
3.85
Open
3.979
Day's Range
3.77-3.99
52 wk Range
3.5-10.42
Volume
11.75K
Average Vol. (3m)
42.55K
1-Year Change
-24.51%
Book Value / Share
-0.7
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TLSI Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
11.917
Upside
+204.005%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

TriSalus Life Sciences Inc Company Profile

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

Compare TLSI to Peers and Sector

Metrics to compare
TLSI
Peers
Sector
Relationship
P/E Ratio
−2.1x−4.0x−0.6x
PEG Ratio
−0.020.070.00
Price / Book
−6.0x2.9x2.6x
Price / LTM Sales
4.5x26.8x3.2x
Upside (Analyst Target)
186.5%213.0%40.6%
Fair Value Upside
Unlock16.6%7.1%Unlock

Analysts' Recommendations

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 11.917

(+204.00% Upside)

People Also Watch

24.20
LARK
0.00%
77.84
CFFI
-1.73%
4.660
RZLT
-5.67%
17.070
PPIH
+0.29%
28.32
FSTR
-2.58%

FAQ

What Is the TriSalus Life Sciences (TLSI) Stock Price Today?

The TriSalus Life Sciences stock price today is 3.92

What Stock Exchange Does TriSalus Life Sciences Trade On?

TriSalus Life Sciences is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for TriSalus Life Sciences?

The stock symbol for TriSalus Life Sciences is "TLSI."

What Is the TriSalus Life Sciences Market Cap?

As of today, TriSalus Life Sciences market cap is 119.53M.

What is TriSalus Life Sciences Earnings Per Share?

The TriSalus Life Sciences EPS is -2.41.

From a Technical Analysis Perspective, Is TLSI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.